C J Griessenauer1, R Gupta2, S Shi2, A Alturki2, R Motiei-Langroudi2, N Adeeb2, C S Ogilvy2, A J Thomas2. 1. From the Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. christoph.griessenauer@gmail.com. 2. From the Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Abstract
BACKGROUND AND PURPOSE: Flow diversion with the Pipeline Embolization Device has emerged as an attractive treatment for cerebral aneurysms. Processes involved in aneurysm occlusion include changes in intra-aneurysmal hemodynamics and endothelialization of the device. Here, we call attention to a radiographic sign not previously reported that is detected in incompletely occluded aneurysms after treatment with the Pipeline Embolization Device at angiographic follow-up and referred to as the "collar sign." MATERIALS AND METHODS: A retrospective review of all patients who underwent placement of a Pipeline Embolization Device for cerebral aneurysms between January 2014 and May 2016 was performed. All aneurysms found to show the collar sign at follow-up were included. Optical coherence tomography was performed in 1 case. RESULTS: One hundred thirty-five aneurysms were treated in 115 patients. At angiographic follow-up, 17 (10.7%) aneurysms were found to be incompletely occluded. Ten (58.8%) of these aneurysms (average diameter, 7.9 ± 5.0 mm) were found to have the collar sign at angiographic follow-up (average, 5.5 ± 1.0 months). Four (40.0%) of the aneurysms underwent a second angiographic follow-up (average, 11.0 ± 0.9 months) after treatment, and again were incompletely occluded and showing the collar sign. Two patients underwent retreatment with a second Pipeline Embolization Device. Optical coherence tomography showed great variability of endothelialization at the proximal end of the Pipeline Embolization Device. CONCLUSIONS: The collar sign appears to be indicative of endothelialization, but continued blood flow into the aneurysm. This is unusual given the processes involved in aneurysm occlusion after placement of the Pipeline Embolization Device and has not been previously reported.
BACKGROUND AND PURPOSE: Flow diversion with the Pipeline Embolization Device has emerged as an attractive treatment for cerebral aneurysms. Processes involved in aneurysm occlusion include changes in intra-aneurysmal hemodynamics and endothelialization of the device. Here, we call attention to a radiographic sign not previously reported that is detected in incompletely occluded aneurysms after treatment with the Pipeline Embolization Device at angiographic follow-up and referred to as the "collar sign." MATERIALS AND METHODS: A retrospective review of all patients who underwent placement of a Pipeline Embolization Device for cerebral aneurysms between January 2014 and May 2016 was performed. All aneurysms found to show the collar sign at follow-up were included. Optical coherence tomography was performed in 1 case. RESULTS: One hundred thirty-five aneurysms were treated in 115 patients. At angiographic follow-up, 17 (10.7%) aneurysms were found to be incompletely occluded. Ten (58.8%) of these aneurysms (average diameter, 7.9 ± 5.0 mm) were found to have the collar sign at angiographic follow-up (average, 5.5 ± 1.0 months). Four (40.0%) of the aneurysms underwent a second angiographic follow-up (average, 11.0 ± 0.9 months) after treatment, and again were incompletely occluded and showing the collar sign. Two patients underwent retreatment with a second Pipeline Embolization Device. Optical coherence tomography showed great variability of endothelialization at the proximal end of the Pipeline Embolization Device. CONCLUSIONS: The collar sign appears to be indicative of endothelialization, but continued blood flow into the aneurysm. This is unusual given the processes involved in aneurysm occlusion after placement of the Pipeline Embolization Device and has not been previously reported.
Authors: I Szikora; Z Berentei; Z Kulcsar; M Marosfoi; Z S Vajda; W Lee; A Berez; P K Nelson Journal: AJNR Am J Neuroradiol Date: 2010-02-11 Impact factor: 3.825
Authors: Peter Kan; Adnan H Siddiqui; Erol Veznedaroglu; Kenneth M Liebman; Mandy J Binning; Travis M Dumont; Christopher S Ogilvy; John R Gaughen; J Mocco; Gregory J Velat; Andrew J Ringer; Babu G Welch; Michael B Horowitz; Kenneth V Snyder; L Nelson Hopkins; Elad I Levy Journal: Neurosurgery Date: 2012-12 Impact factor: 4.654
Authors: C J O'Kelly; J Spears; M Chow; J Wong; M Boulton; A Weill; R A Willinsky; M Kelly; T R Marotta Journal: AJNR Am J Neuroradiol Date: 2012-08-02 Impact factor: 3.825
Authors: N Adeeb; J M Moore; M Wirtz; C J Griessenauer; P M Foreman; H Shallwani; R Gupta; A A Dmytriw; R Motiei-Langroudi; A Alturki; M R Harrigan; A H Siddiqui; E I Levy; A J Thomas; C S Ogilvy Journal: AJNR Am J Neuroradiol Date: 2017-09-14 Impact factor: 3.825
Authors: Matthew J Gounis; Giovanni J Ughi; Miklos Marosfoi; Demetrius K Lopes; David Fiorella; Hiram G Bezerra; Conrad W Liang; Ajit S Puri Journal: Stroke Date: 2018-11-29 Impact factor: 7.914
Authors: S Gomez-Paz; Y Akamatsu; J M Moore; C S Ogilvy; A J Thomas; C J Griessenauer Journal: AJNR Am J Neuroradiol Date: 2020-02-13 Impact factor: 3.825
Authors: Ran Xu; Qing Zhao; Tao Wang; Yutong Yang; Jichang Luo; Xiao Zhang; Yao Feng; Yan Ma; Adam A Dmytriw; Ge Yang; Shengpan Chen; Bin Yang; Liqun Jiao Journal: Transl Stroke Res Date: 2022-04-21 Impact factor: 6.829
Authors: Benjamin Csippa; Dániel Gyürki; Gábor Závodszky; István Szikora; György Paál Journal: Cardiovasc Eng Technol Date: 2019-12-03 Impact factor: 2.495